Basic Information
Basic information for MIR9-3HG-213-12aa-1
Peptide Name MIR9-3HG-213-12aa-1
Genome Position chr15:89362585-89362620[+]
Species Human
Peptide Sequence MRSPGQGRPEGG
Peptide Length 12
Unique No (MIR9-3HG-211-12aa,MIR9-3HG-214-12aa-2,MIR9-3HG-218-12aa-2,MIR9-3HG-219-12aa-1,MIR9-3HG-226-12aa-2,MIR9-3HG-227-12aa-2)
Grand Average of Hydropathicity -1.6417
Relative Molecular Mass 1426.52
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000654171;MIR9-3HG-213
Transcript Length 4350
Coding Ability 0.4352
DNA Sequence Corresponding to Peptide ATGCGCTCGCCGGGGCAGGGGCGCCCGGAGGGCGGC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :